Hypertension in renal failure

Disease-a-Month

Volumn 44, Issue 6, 1998, Pages 243-253

  Townsend, R R ^a   Cirigliano, M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ANTIHYPERTENSIVE THERAPY; CLINICAL PROTOCOL; HUMAN; HYPERTENSION; KIDNEY FAILURE; KIDNEY FUNCTION; PATHOPHYSIOLOGY; REVIEW; TREATMENT INDICATION;

EID: 0031828888     PISSN: 00115029     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-5029(98)90002-5     Document Type: Article

References (30)

1. Sinclair AM, Isles CG, Brown I, et al. Secondary hypertension in a blood pressure clinic. Arch Intern Med 1987;147:1289-93.
2. Klahr S. The kidney in hypertension - villain and victim. N Engl J Med 1989;320:731-3.
3. Pohl MA. The ischemic kidney and hypertension. Am J Kid Dis 1993;21(5 Suppl 2):23-8.
4. Greco BA, Breyer JA. The natural history of renal artery stenosis: who should be evaluated for suspected ischemic nephropathy. Semin Nephrol 1996;16:2-11.
5. US Renal Data Systems (USRDS) 1996 Annual Data Report. Bethesda [MD]: The National Institutes of Diabetes and Digestive and Kidneys Diseases, 1996.
6. Buckalew VM Jr., Berg RL, Wang SR, et al. Prevalence of hypertension in 1,795 subjects with chronic renal disease: The Modification of Diet in Renal Disease study baseline cohort. Am J Kid Dis 1996;28:811-21.
7. Shulman NB, Ford CE, Hall DW, et al. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function: results from the Hypertension Detection and Follow-up Program. Hypertension 1989;13(Suppl I):80-93.
8. National High Blood Pressure Education Program Working Group. 1995 update of the Working Group reports on chronic renal failure and renovascular hypertension. Arch Intern Med 1996;156:1938-47.
9. Klag MJ, Whelton PK, Randall BL, et al. Blood pressure and end-stage renal disease in men. N Engl J Med 1996;334:13-8.
10. Rostand SG, Brown G, Kirk KA, et al. Renal insufficiency in treated essential hypertension. N Engl J Med 1989;320:684-8.
11. Joint National Committee for the Detection, Evaluation, and Treatment of High Blood Pressure. The fifth report of the Joint National Committee for the Detection, Evaluation and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993;153:154-83.
12. Freedman BI, Iskander SS, Appel RG. The link between hypertension and nephrosclerosis. Am J Kid Dis 1995;25:207-21.
13. Fogo A, Breyer JA, Smith MC, et al. Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: a report from the African American Study of Kidney Disease (AASK) Trial. Kidney Int 1997;51:244-52.
14. Preston RA, Epstein M. Renal parenchymal disease and hypertension. Am J Kid Dis 1996;15:138-51.
15. Ganguly A, Gribble J, Tune B, et al. Renin-secreting Wilms' tumor with severe hypertension: report of a case and a brief review of renin-secreting tumors. Ann Intern Med 1973;79:835-7.
16. Smith HW. Unilateral nephrectomy in hypertensive disease. J Urol 1956;76:685-701.
17. Luke RG, Kennedy AC, Briggs JD. Results of nephrectomy in hypertension associated with unilateral renal disease. Br Med J 1968:3:764-8.
18. Kiprov DD, Colvin RB, McCluskey RT. Focal and segmental glomerulosclerosis and proteinuria associated with unilateral renal agenesis. Lab Invest 1982;46:275-81.
19. Rugiu C, Oldrizzi L, Lupo A, et al. Clinical features of patients with solitary kidneys. Nephron 1986;43:10-5.
20. Weiland D, Sutherland DER, Chavers B, et al. Information on 628 living-related kidney donors at a single institution, with long-term follow-up in 472 cases. Transplant Proc 1984;16:5-7.
21. Williams SL, Oler J-G, Jorkasky DK. Long-term renal function in kidney donors: a comparison of donors and their siblings. Ann Intern Med 1986;105:1-8.
22. Hakim RM, Goldszer RC, Brenner BM. Hypertension and proteinuria: long-term sequelae of uninephrectomy in humans. Kidney Int 1984;25:930-6.
23. Lewis EJ, Hunsicker LG, Bain RP, et al. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993;329:1456-62.
24. Maschio G, Alberti D, Janin G, et al. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency N Engl J Med 1996;334:939-45.
25. Hricik DE, Browning PJ, Kopelman R, et al. Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenoses or renal-artery stenosis in a solitary kidney. N Engl J Med 1983;308:373-6.
26. Zucchelli P, Zuccala A, Borghi M, et al. Long-term comparison between captopril and nifedipine in the progression of renal insufficiency. Kidney Int 1992;42:452-8.
27. Mimran A. Antihypertensive therapy and renal function. J Cardiovasc Pharmacol 1996;27(Suppl 3):S19-25.
28. Eknoyen G, Suki WN. Renal consequences of antihypertensive therapy. Semin Nephrol 1991;11:129-37.
29. Klahr S, Levey AS, Beck GJ, et al. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease: Modification of Diet in Renal Disease Study Group. N Engl J Med 1993;330:877-84.
30. Burt VL, Cutler JA, Higgins M, et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population: data from the health examination surveys 1960 to 1961. Hypertension 1995;26:60-9.